Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Lisata Therapeutics, Inc.
Pharmaceutical Preparation ManufacturingUnited States
Last verified 12 days agolisata.com
Lisata Therapeutics, Inc., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 2018, the company has rapidly established itself as a leader in developing innovative therapeutic solutions, particularly in the realm of oncology and rare diseases.
With a focus on advanced drug formulations and delivery systems, Lisata Therapeutics offers unique products that address unmet medical needs, setting them apart in a competitive market. The company’s commitment to research and development has led to significant milestones, including successful clinical trials and strategic partnerships that enhance its market position.
Lisata Therapeutics continues to drive advancements in pharmaceutical manufacturing, aiming to improve patient outcomes through its cutting-edge therapies and dedication to excellence in the healthcare sector.
23
DitchCarbon score
-19 vs industry average
Lisata Therapeutics, Inc.’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Lisata Therapeutics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2025
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Lisata Therapeutics, Inc.'s reported carbon emissions
Lisata Therapeutics, Inc. (based in the US, Pharmaceutical Preparation Manufacturing industry) reported its 2022 Scope 1 emissions as 404,000 kg CO2e and Scope 2 emissions as 282,600 kg CO2e. For 2021, the company disclosed Scope 1 emissions of 533,000,000 kg CO2e. There is no publicly available data on their Scope 3 emissions or specific climate reduction targets. The company does not currently have any Science Based Targets initiative (SBTi) commitments or a Climate Pledge.
Assessing Lisata Therapeutics, Inc. as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Lisata Therapeutics, Inc. and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Lisata Therapeutics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Lisata Therapeutics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Lisata Therapeutics, Inc.12 days ago
23
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more